Related Experiment Videos
[Risks of therapy in infectious shock].
Revista De Igiena, Bacteriologie, Virusologie, Parazitologie, Epidemiologie, Pneumoftiziologie. Bacteriologia, Virusologia, Parazitologia, Epidemiologia
|January 1, 1978
Summary
Polyvalent therapy for septic shock can cause iatrogenic adverse effects. Medical staff in intensive therapy units must be aware of potential drug interactions and cumulative effects.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Intensive Care
Background:
- Septic shock management involves complex polyvalent therapies.
- Understanding drug interactions and adverse effects is crucial in intensive care settings.
- Pharmacokinetic data can inform the assessment of therapeutic interventions.
Purpose of the Study:
- To discuss adverse effects of polyvalent therapy in septic shock.
- To identify potential iatrogenic pathointerference from combined treatments.
- To highlight the importance of considering cumulative drug effects.
Main Methods:
- Review of intensive therapy unit experience.
- Correlation with modern pharmacokinetic data.
- Discussion of adverse effects from various therapeutic agents.
Main Results:
- Polyvalent therapy in septic shock can lead to iatrogenic adverse effects.
- Potential adverse effects arise from antibiotics, corticosteroids, plasma expanders, and other agents.
- Cumulative effects of multiple therapies can exacerbate patient conditions.
Conclusions:
- Awareness of potential adverse effects from polyvalent therapy is essential for intensive care staff.
- Guidelines for medical staff should address the summation of effects from combined treatments.
- Minimizing iatrogenic complications requires careful consideration of all administered therapies.